Abpro: Funding, Investors & Team (Sep 2026)
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
Abpro has raised $2.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Nov 2024.
Abpro Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Abpro Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Abpro raised $2.0M in an undisclosed round announced in Apr 2022.
2.6 years later, an undisclosed round was announced in Nov 2024 with no disclosed amount.
Abpro Founders and Leadership Team
Contact details for the Abpro team: 1 of 2 have an email address on file.
Start 14-day free trial →Abpro Funding Compared to Other Biotechnology Startups
Funded Startups Like Abpro in Biotechnology and Woburn
Companies Similar to Abpro
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Abpro Funding FAQs
What does Abpro do?
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
How much funding has Abpro raised?
Abpro has raised $2.0M across 2 rounds on record.
When did Abpro last raise funding?
Abpro's most recent funding round on record was announced in Nov 2024. The amount was not disclosed.
Who founded Abpro?
FundedIQ lists Eugene Cha (Founder) at Abpro.
Who is the CEO of Abpro?
Ian Chan is listed as CEO at Abpro.
Where is Abpro headquartered?
Abpro is based in Woburn, Massachusetts, United States.
How many employees does Abpro have?
Abpro is in the 11-50 employee band.
About FundedIQ's Abpro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Abpro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.